News
Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic, Wegovy, and Zepbound—or spacing out doses longer than ...
Median annual list price for new drugs over $370,000 in 2024 72% of new drugs in 2024 for orphan diseases Drugmakers emphasize value, offer savings programs amid rising list prices May 22 (Reuters ...
Guards in Costa Rica have intercepted an unusual prison drug delivery, catching a cat as it jumped over the periphery fence at night with marijuana and crack taped to its body. The black-and-white ...
The prison officials discovered the cat sneaking over a barbed wire fence, according to video posted online Prison officials in Costa Rica caught an unlikely suspect attempting to smuggle drugs ...
"So, yes, a large portion of patients starting GLP-1 drugs are already dealing with mental health struggles. But that’s not because of the drug — that’s because of the disease." Once these ...
Weight loss drugs are popular for helping patients quickly shed pounds Drugs like Ozempic are controversial for their side effects Side effects of some drugs can range from nausea to kidney ...
"I actually ended up having a kidney stone, ended up in an endocrinologist office, and he said, 'Do you want to try the new GLP-1 drugs?'" he recounted. Kessler, who was studying them at the time ...
In recent years, Kessler has lost considerable weight himself with the help of the new GLP-1 drugs. He describes his weight loss and analyzes the drugs and their potential societal impact in his ...
Listen to more stories on the Noa app. Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and researchers have struggled to ...
President Trump vowed to bring “FAIRNESS TO AMERICA!” by deeply slashing prescription drug prices through an executive order he plans to sign Monday morning. Trump promised to implement what ...
Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...
The World Health Organization (WHO) on Thursday announced its support for weight-loss drugs in adults globally. The organization plans to back GLP-1s like Wegovy and Zepbound to treat obesity in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results